Latest news
Gut enzyme links microbiota, barrier dysfunction and MASH progression
Metabolic dysfunction-associated steatohepatitis (MASH) is often viewed through the lens of hepatic lipid accumulation, inflammation and fibrosis. A new study identifies intestinal neutral ceramidase as a gut-derived driver of MASH progression through its effects on microbial metabolism, epithelial signalling and intestinal barrier function.
Anti-cancer molecules show promise in the fight against malaria
Molecules known for their anti-cancer activity have proven effective in combating Plasmodium falciparum, the parasite that causes malaria. Researchers also investigated how differences in the structure of these molecules affect their impact on the parasites.
Honeybee silk could power smarter wound dressings
Recombinant honeybee silk can be bioengineered in a lab, allowing researchers to modify the protein sequence and potentially introduce new features into the materials, such as infection-sensing signals or targeted drug release.
APIC and SHEA Statement on reported erosion of CDC capacity
Reports that the CDC has lost nearly a third of its workforce, including experienced scientists in its emerging infectious disease and respiratory disease centers, means guidance is slower to arrive, technical assistance is harder to reach, and scientific expertise is thinner at a time when most needed, experts warn.
Promega launches Paradyme™ 27GY STR System, mnimising stutter artifacts in forensic DNA analysis
Promega Corporation has launched Paradyme™ 27GY STR System, the first commercially available short tandem repeat (STR) analysis kit to include the company’s Reduced-Stutter Polymerase (RSP). This novel enzyme significantly reduces the most common type of confounding artifact in forensic DNA analysis.
Groundbreaking research to sequence Antarctic genomes from microbes to whales
A molecular microbial ecologist and biological oceanographer has been awarded $18.4 million to lead a project that will pave the way for the next generation of Antarctic research. This research infrastructure will enable researchers to understand how Antarctic life has evolved and adapted to extreme conditions, while also seeding innovation.
Gut enzyme links microbiota, barrier dysfunction and MASH progression
Metabolic dysfunction-associated steatohepatitis (MASH) is often viewed through the lens of hepatic lipid accumulation, inflammation and fibrosis. A new study identifies intestinal neutral ceramidase as a gut-derived driver of MASH progression through its effects on microbial metabolism, epithelial signalling and intestinal barrier function.
Anti-cancer molecules show promise in the fight against malaria
Molecules known for their anti-cancer activity have proven effective in combating Plasmodium falciparum, the parasite that causes malaria. Researchers also investigated how differences in the structure of these molecules affect their impact on the parasites.
About 1 in 3 Americans say RFK Jr. recommends measles vaccination
The number of measles cases in the United States is at the highest level in decades, attributed to a decrease in vaccination against measles. The public remains evenly divided on whether or not U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recommends the MMR vaccine.
AFYREN and Terrial renew their partnership for French-manufactured potash fertilizers
AFYREN and Terrial today announce the renewal of their strategic partnership with the signing of a new multi-year fertilizer supply contract, worth several tens of millions of euros This long-term contract strengthens both companies’ commitment to making French agriculture more sustainable and less dependent on international fertilizer markets.
Sharpening an essential tool for biotechnology
Scientists develop a database of validated guide RNAs to improve engineering of microbes for manufacturing applications.
Green hydrogen production and storage using alcohols, iron, and baker’s yeast
A new recyclable system uses baker’s yeast to store H₂ in organic molecules and iron ions to release it when needed - offering a promising route toward more sustainable hydrogen production and storage.
Honeybee silk could power smarter wound dressings
Recombinant honeybee silk can be bioengineered in a lab, allowing researchers to modify the protein sequence and potentially introduce new features into the materials, such as infection-sensing signals or targeted drug release.
Scientists overcome key barrier to self-amplifying vaccines
Scientists have overcome a key barrier to self-amplifying vaccines. The innovation could enable protection at lower doses, meaning vaccines could be rolled out further and faster than was previously imaginable. saRNA vaccines hold great promise but are hindered by an inherent flaw which undermines their effectiveness.
Wearable nanotech could combat nerve agents
Fungi-inspired nanoparticles could someday provide a new way to help soldiers fight back against deadly nerve agents on the frontline. Scientists developed a nanoparticle-based compound that, when mixed into clothing dyes, could limit the impact of chemicals commonly found in pesticides, insecticides and nerve agents.
APIC and SHEA Statement on reported erosion of CDC capacity
Reports that the CDC has lost nearly a third of its workforce, including experienced scientists in its emerging infectious disease and respiratory disease centers, means guidance is slower to arrive, technical assistance is harder to reach, and scientific expertise is thinner at a time when most needed, experts warn.
Groundbreaking research to sequence Antarctic genomes from microbes to whales
A molecular microbial ecologist and biological oceanographer has been awarded $18.4 million to lead a project that will pave the way for the next generation of Antarctic research. This research infrastructure will enable researchers to understand how Antarctic life has evolved and adapted to extreme conditions, while also seeding innovation.
WHO reports latest global trends in cholera, meningitis and plague
Cholera deaths increased by 30% in 2025, despite fewer cases being reported to the World Health Organization (WHO). In 2025, 47 countries reported 451 499 cholera cases and 7870 deaths to WHO, the highest number of annual cholera deaths reported to WHO since 1999.